Sharon is a health economist with over twenty years of diverse experience in the pharmaceutical industry in both global and Australian based roles. She has a deep and comprehensive understanding of drug development and commercialisation.
Sharon runs her own consulting company, working largely with life science organisations, advising on reimbursement and pricing strategies to ensure rapid and equitable access for patients to life changing medicines.